bf/NASDAQ:GANX_icon.png

NASDAQ:GANX

Gain Therapeutics, Inc.

  • Stock

USD

Last Close

2.23

08/11 21:00

Market Cap

21.66M

Beta: 0.35

Volume Today

155.91K

Avg: 82.23K

PE Ratio

−2.52

PFCF: −5.26

Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietary small molecules that bind these...Show More

Earnings

Earnings per Share (Estimate*)

-0.6-0.5-0.4-0.3-0.2-0.12018-03-312019-09-302021-05-102022-08-082023-11-14

Revenue (Estimate*)

200K400K600K800K1M2018-03-312019-09-302021-05-102022-08-082023-11-14

*Estimate based on analyst consensus